UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping

Oct.04.2024
UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping
A UK study shows that there are 5.1 million e-cigarette users among people aged 16 and over, with the usage rate highest among the 16-24 age group at 15.8%. Over 1 million non-regular smokers have started using e-cigarettes, with usage increasing sevenfold over the past three years.

According to a recent report by The Guardian, research data shows that one in every ten people aged 16 and above in the UK is using e-cigarettes. The number of non-regular smokers in the UK who have started using e-cigarettes has increased sevenfold in three years, reaching 1 million. This has raised concerns among health experts.


Before 2021, the usage of e-cigarettes among non-regular adult smokers remained stable, with approximately 1 in 200 people, or about 133,000 individuals, using e-cigarettes. However, a study published in The Lancet Public Health indicates that by 2024, this proportion is projected to increase sharply to 1 in every 28 people, equating to 1.006 million individuals.


Data released this week by the Office for National Statistics in the UK reveals that there are a total of 5.1 million e-cigarette users aged 16 and over in the country. The age group with the highest e-cigarette usage rate is 16 to 24-year-olds, with a rate of 15.8%.


The study also found that the majority of e-cigarette users who had never smoked regularly are using e-cigarettes on a daily basis and for longer periods of time. This sharp increase is mainly driven by young people, with research showing that 14% of non-regular smokers aged 18 to 24 in the UK are now using e-cigarettes.


Researchers warn that the UK government's plans to ban disposable e-cigarettes may not fully address the issue, as some brands have already introduced reusable products. Experts suggest that reducing the appeal of e-cigarette products may require stricter regulations and laws.


Professor Jamie Brown from the Institute of Epidemiology and Health Care at University College London (UCL) believes that although measures to ban disposable e-cigarettes may not be enough to solve the problem, stricter regulations on the appearance, packaging, and marketing of products could be introduced. These measures are unlikely to reduce the effectiveness of e-cigarettes in smoking cessation. He points out that by 2023, the overall prevalence of e-cigarettes seems to be stabilizing, which may provide a reasonable basis for implementing these measures and assessing their effectiveness.


The study analyzed survey data from 153,073 adults in the UK between 2016 and 2024, of which 94,107 had never smoked regularly. The data showed that the proportion of non-smokers who used e-cigarettes increased from 0.5% in 2016-2020 to 3.5% by April 2024, surpassing 1 million people, with over half of them aged between 18 and 24.


Researchers also found that in recent years, the group of people who smoke irregularly tends to be younger, with an increase in the proportion of women. They are more likely to use disposable devices and high-concentration nicotine e-cigarette liquid, and mainly purchase products in supermarkets or convenience stores.


In a statement released by the Department of Health and Social Welfare in the UK, the department emphasized that although e-cigarettes can effectively help adults quit smoking, children and non-smoking adults should not use e-cigarettes. The department stated that the Tobacco and E-cigarette Act will protect future generations from the harms of tobacco and nicotine, save countless lives, and alleviate pressure on the national healthcare system.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14